Limited health literacy is a major barrier to heart disease prevention and treatment
- Details
- Written by Darcy Spitz
- Category: Health News
Dallas, Texas - Limited healthy literacy is a major barrier blocking many people from achieving good cardiovascular health or benefiting from effective treatment for heart attacks, heart failure, strokes and other cardiovascular diseases, according to a scientific statement published in the American Heart Association’s journal Circulation.
Eosinophilic esophagitis may be due to missing protein
- Details
- Written by Judith Lavelle
- Category: Health News
Washington, DC - Scientists have discovered that the absence of a specific protein in cells lining the esophagus may cause inflammation and tissue damage in people with eosinophilic esophagitis (EoE). EoE affects as many as 150,000 people in the United States, many of whom are children. People with EoE experience difficult or painful swallowing, vomiting and nutritional problems because an accumulation of immune cells called eosinophils scars the esophagus.
New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments
- Details
- Written by NIH
- Category: Health News
Washington, DC - A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI’s Center for Cancer Research (CCR), and the findings were published June 4, 2018 in Nature Medicine. NCI is part of the National Institutes of Health.
Signing of the Right to Try Act
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
- Category: Health News
Washington, DC - For patients with serious or immediately life-threatening diseases, the FDA remains committed to enhancing access to promising investigational medicines for those unable to access products through clinical trials. This is the mission of our expanded access program. The agency is dedicated to these purposes, and it has been for more than three decades.
Solving America’s medication adherence epidemic
- Details
- Written by Tom Coyne
- Category: Health News
West Lafayette, Indiana - A Purdue-affiliated startup is developing a low-cost, high-tech solution to address the nationwide health crisis of Americans failing to take their medicine as prescribed. The Internet of Things system reminds patients to take medications and quickly alerts caregivers or providers when intervention is needed.
FDA approves new treatment for moderately to severely active ulcerative colitis
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication. Other FDA-approved treatments for the chronic treatment of moderately to severely active ulcerative colitis must be administered through an intravenous infusion or subcutaneous injection.
Page 2921 of 3785